*NEWS: Axonics Drops In IPO
This article is courtesy of SoCal Tech, with whom OCSN has a partnership with:
Irvine-based Axonics Modulation Technologies, which is developing medical devices for treating overactive bladder, fecal incontinence and urinary retention, has had its IPO debut, pricing its IPO last night at $15.00 per share. The company’s stock dropping in trading on Wednesday, falling to around $14.85 in afternoon trading. Axonics sold 8,000,000 shares of its common stock in the offering. The company is now trading as AXNX on the Nasdaw Global Select market.